THE MIDDLEBY CORPORATION (MIDD): what the price assumes

In the published model solve dated 2026-Q2, anchored at $135.61, THE MIDDLEBY CORPORATION (MIDD) is priced for +5.7% growth. boothcheck publishes no house fair value, target price, or buy/sell rating; individual model outputs and user-controlled scenarios are analytical inputs, not Boothcheck targets. Narrative composed 2026-06-27.

Generated: 2026-08-10 · Exported: 2026-08-12 · Source: https://boothcheck.com/report/MIDD

Headline

FieldValue
TickerMIDD
CompanyTHE MIDDLEBY CORPORATION
Current price$135.61/sh
CompositionCommercial Foodservice 73% / Food Processing 27%

What The Price Assumes (Inversion)

The assumption today's price embeds, recovered by inverting the valuation.

FieldValue
Inversion basiswhole-company
Implied growth5.7%
Multiple paid15x mid-cycle operating income

Solve inputs: computed at a 9.1% cost of capital with 4% terminal growth over a 5-year stage; each 1pp of cost of capital moves the implied operating-profit growth ~6pp.

How unusual the bet is: within-range (limited comparison data)

ReferenceValue
vs own history-0.31σ
implied end-window share0%

Valuation X-Ray

Asset, earnings-power and peer-multiple models all land far below the price; ONLY the growth-DCF reaches it. The bet is durable compounding the static frames structurally cannot price (a moat/durability premium).

How the valuation models price the stock relative to the market price. Price/FV above 1.0 means the market pays more than that lens defends (expensive); at or below 1.0 the lens can defend the price.

FamilyMedian price/FVModelsReads
Asset2.87x3expensive
Earnings1.69x3expensive
Relative0
Growth0.86x3justifies

Families that justify the price: Growth Families that call it expensive: Asset, Earnings

The models below discount at their own flat-beta convention rates (cost of equity 9.3%, WACC 8.0%); the inversion above states its own rate.

Per-Model Detail (n=9)

ModelFamilyFVPrice/FVApplicableMethodology
DCF Perpetual GrowthGrowth$254.100.53xyesFCF base $0.5B, growth 6% (input: historical growth), terminal g 4.0%, WACC 8.0%, 6yr projection
DCF Exit MultipleGrowth$158.340.86xyesExit EV/EBITDA: 9.8x / 11.8x / 13.8x (bear / base = today's held flat / bull), 6yr
Relative ValuationRelativenoP/S fallback (negative EPS): Sector P/S 2.5x × TTM revenue — excluded from consensus
Simple DDMGrowthno
Two-Stage DDMGrowthno
Simple Excess ReturnAsset$52.532.58xyesReference only (book value floor): BV/sh $52.53, ROE negative
Two-Stage Excess ReturnAsset$47.272.87xyesReference only (book value with convergence): BV/sh $52.53, ROE converges to ke
Discounted Future Market CapGrowth$103.761.31xyesRev $3.3B, growth 6% (input: historical growth; tapered), Terminal P/S: 1.5x / 1.9x / 2.2x (bear / base = today's held flat / bull, cap 8x)
Peter Lynch Fair ValueRelative$0.00noNegative/zero EPS — earnings-based value floored at $0
Margin TrajectoryGrowthno
Earnings Power ValueEarnings$121.491.12xyesNormalized EBIT (5y avg op income, one-time charges added back) $0.78B × (1−24%) / WACC 8.0% → EPV (no growth)
Residual IncomeAssetno
Graham NumberAssetno
EV/EBITDA RelativeRelativenoEBITDA $0.67B × sector EV/EBITDA 12.0x
FCF YieldEarnings$80.141.69xyesFCF $494.1M / Kₑ 9.3% — zero-growth perpetuity
SBC-Adj FCF YieldEarnings$75.011.81xyesSBC-adj FCF $0.47B (FCF $0.49B − SBC $0.02B) capitalized at Kₑ
Ben Graham FormulaEarningsno
ROIC-Justified P/BAsset$16.248.35xyesBV $52.53 × (ROIC 2.5% / WACC 8.0%)
P/Sales SectorRelativenoRevenue $3.31B × sector P/S 2.5x
PEG Fair ValueRelativeno
Earnings YieldEarningsno
Funds From Operations MultipleRelativeno
Clinical Phase NPVGrowthno
MertonAssetno
V5 Mechanicalno

Economic-Unit Decomposition (Sum Of The Parts)

One or more material disclosed units has unresolved economics. Unknown/general is not evidence of homogeneity: segment SOTP is primary but incomplete, consolidated cash flow may remain only a secondary cross-check when every unit shares an enterprise basis, and one sector multiple or target margin is withheld.

UnitRoleValuation basisRevenueReported profitValue evidenceStatus
Commercial Foodserviceoperatingenterprise$2.4b$626.7m operating-incomewithheldunresolved no unit value
Food Processingoperatingenterprise$850.2m$171.5m operating-incomewithheldunresolved no unit value

No total common-equity value is stated. One or more material units lack a supported unit value. The displayed values are an indicative subtotal; consolidated debt and cash cannot be applied to a fraction of the company.

Solvency

FieldValue
Net debt$2.2b
Share count CAGR (buyback)-4.3%
Burning cashno

Operating profit is negative or near zero and the company has no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so years-to-repay cannot be computed honestly.

Operating profit is negative or near zero and there is no demonstrated through-cycle (mid-cycle) operating margin to normalize against, so interest coverage cannot be computed honestly.

Bullet Takeaways

Bull Case

The balance sheet tells you what management actually believes about its own business. Net debt of roughly $2.2 billion against trailing operating income near $579 million is real leverage, about four times, but the more telling number is the share count, which has been shrinking around 4% a year. A company carrying meaningful debt that still chooses to retire its own stock is signaling that it views the equity as cheaper than paying down the next dollar of debt. That is a confidence statement, and the upcoming breakup is the structural version of the same bet: Middleby is splitting into two public companies precisely because management thinks the parts are worth more than the conglomerate.

The operating engine supports that confidence. Gross margin ran at 39.1% in fiscal 2025, and the business throws off substantial free cash, roughly half a billion dollars on a trailing basis, because equipment sales pull along a recurring stream of aftermarket parts and service tied to the installed base. The first quarter showed both segments accelerating: Food Processing grew 25% organically with record orders and a fifth straight quarter of book-to-bill above one, while Commercial Foodservice grew 8.1% organically. Order momentum that strong is the leading edge of revenue, and it is why management raised full-year guidance to adjusted EPS of $9.54 to $9.70 for fiscal 2026.

The spin-off is the catalyst the bull case has been waiting for. Splitting Food Processing into a separately listed company, Midera, targeted for early July 2026, lets each business carry the multiple its growth and margin profile deserves rather than a blended one that satisfies neither. The remaining Middleby keeps the larger, steadier commercial-foodservice franchise; the spun business takes a faster-growing food-processing order book into its own currency. The company has paired the breakup with an asset sale and a delevering plan, so the equity story is not just a financial-engineering reshuffle. It is a cleaner, less-levered pair of businesses that the market can value on their own terms.

Bear Case

The structural truth a holder has to face is that the price is paying for a normalization and a re-rating that have not happened yet. Strip the trailing year of its one-time charges and the business earns a healthy through-cycle margin near 17%, but at $172.46 (June 27, 2026) the market is paying about seventeen times that normalized operating income, which inverts to roughly 14% annual operating growth sustained for five years. That is not an impossible rate for Middleby in a good stretch, but history is sobering: only about 46% of comparable fast-growers have held that pace for even five years. The price assumes Middleby lands in the better half, and it assumes the breakup unlocks the value rather than merely rearranging it.

Leverage is the amplifier on every other risk. Net debt of roughly $2.2 billion is about four times trailing operating income, and the company's own post-spin plan calls for the remaining business to start near 2.8 times and work down toward 2.5 times. In a benign environment that is manageable; the concern is the combination of debt with the acquisitive history that built it. Middleby grew by buying brands, and the goodwill and intangibles that come with that strategy are valued against "comparable publicly traded companies with similar operating and investment characteristics of the reporting units", which means a softer end-market or a lower peer multiple can force impairment charges, the same kind of non-cash hit that depressed the trailing earnings in the first place. A levered roll-up is most exposed precisely when its acquired assets are worth less than their carrying value.

Competition and cyclicality round out the bear. The company concedes that "some competitors have different pricing structures and may be able to deliver their products at lower prices," and capital-equipment demand swings with restaurant and food-processor capital budgets, which tighten when financing costs rise. The spin-off itself carries execution risk: separation costs, two new cost structures, and the possibility that the sum of the parts trades no higher than the whole if either business stumbles in its first independent quarters. The bull sees the breakup unlocking value; the bear notes that the value is unlocked only if both businesses grow into the multiples the price already assigns them, while servicing the debt that financed the empire.

Valuation

Because the trailing year was depressed by one-time charges, the cleanest read of the price uses Middleby's own through-cycle economics, not the trough. On that basis the market is paying about seventeen times normalized operating income, which inverts to roughly 14% annual operating growth held for five years. That is a demanding but not absurd expectation for a company whose two segments grew 25% and 8% organically last quarter, with the caveat that sustaining mid-teens growth for half a decade is something fewer than half of comparable fast-growers have managed.

The methods split the way they usually do for a leveraged, acquisition-built compounder. The peer-multiple and growth-cash-flow lenses sit close to the price: a sector EV/EBITDA near twelve times and the exit-multiple cash-flow method both land within striking distance of $172.46. The asset-value and earnings-power lenses say expensive, and the reason is mechanical: the trailing earnings are negative on a reported basis, so book-value-plus-profitability math, which keys off return on equity, produces a low figure, and the earnings-power method capitalizes a normalized operating profit that does not credit the growth the price is paying for. The honest reading is that this is a growth-and-quality bet, not a value one. The static asset lenses cannot frame a business whose worth is in its franchise and its order book, not its balance-sheet equity.

Solvency is where the discipline has to live. Net debt of about $2.2 billion against trailing operating income near $579 million is roughly four times, with only modest liquid assets against it, and interest expense is not separately broken out in the latest filings. The company generates strong free cash, near half a billion dollars trailing, which is what services the debt and funds the buybacks. The decisive number going forward is the post-spin leverage path: management targets the remaining business around 2.8 times moving toward 2.5 times, and the food-processing spin at roughly 1.25 times. If those targets hold, the equity in each piece sits on a cleaner balance sheet and a clearer growth profile. The price is already paying for that outcome, which is why the execution of the breakup, not the quarter-to-quarter print, is what the valuation rests on.

Catalysts

The dominant catalyst is the Food Processing spin-off. Middleby plans to separate the segment into an independent public company, Midera Food Processing, targeted for July 6, 2026, pending customary conditions and regulatory approval, creating two listed businesses with distinct growth and margin profiles. Oppenheimer initiated coverage at Outperform ahead of the separation, framing the breakup as a potential closer of the valuation gap. The mechanics matter for the equity: post-spin, the remaining Middleby is targeted near 2.8 times net leverage with a goal of reaching 2.5 times by year-end, while the spun food-processing business starts near 1.25 times.

The first quarter set the stage. Middleby reported adjusted EPS of $2.16 against a $1.94 estimate, on revenue of $839.9 million that also beat, with Food Processing up 25% organically and a fifth straight quarter of book-to-bill above one, and Commercial Foodservice up 8.1% organically. Management raised full-year guidance to revenue of $3.36 billion to $3.44 billion and adjusted EPS of $9.54 to $9.70 for fiscal 2026. The watch items into the back half of the year are the clean execution of the separation, the pace of order conversion in both segments, and the delevering trajectory, all of which feed the thesis that two focused companies earn higher multiples than the combined one did.

Peer Cohorts (Per Segment, With Filing Citations)

Commercial Foodservice (reported)

Food Processing (reported)

Methodology Note

Fundamentals sourced from SEC EDGAR filings. Current price from Databento. The priced-in inversion and valuation x-ray are computed by the boothcheck engine; narrative composed by AI from the structured data.

Sources

Middleby Q1 2026 materials, June 2026 · Middleby FY2025 10-K

View the full interactive MIDD report on boothcheck